Drugs in liver disease

被引：18

作者：

Branch, RA ^{[1
]}

机构：

[1] Univ Pittsburgh, Sch Med, Ctr Clin Pharmacol, Pittsburgh, PA 15260 USA

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1998年 / 64卷 / 04期

关键词：

D O I：

10.1016/S0009-9236(98)90077-7

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：462 / 465

页数：4

相关论文

共 13 条

[1] Selective effect of liver disease on the activities of specific metabolizing enzymes: Investigation of cytochromes P450 2C19 and 2D6
Adedoyin, A
Arns, PA
Richards, WO
Wilkinson, GR
Branch, RA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (01) : 8 - 17
[2] ADEDOYIN A, 1996, HEPATOLOGY TXB LIVER, V1, P307
[3] Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis
Arns, PA
Adedoyin, A
DiBisceglie, AM
Waggoner, JG
Hoofnagle, JH
Wilkinson, GR
Branch, RA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (05) : 527 - 537
[4] THE METABOLISM AND BIOAVAILABILITY OF MORPHINE IN PATIENTS WITH SEVERE LIVER-CIRRHOSIS
HASSELSTROM, J
ERIKSSON, S
PERSSON, A
RANE, A
SVENSSON, JO
SAWE, J
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 29 (03) : 289 - 297
[5] KRAUS JW, 1978, CLIN PHARMACOL THER, V24, P411
[6] KUBISTY CA, 1995, POCKET BOOK CRITICAL, P91
[7] THE DISPOSITION OF DAPSONE IN CIRRHOSIS
MAY, DG
ARNS, PA
RICHARDS, WO
PORTER, J
RYDER, D
FLEMING, CM
WILKINSON, GR
BRANCH, RA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (06) : 689 - 700
[8] PATWARDHAN RV, 1981, GASTROENTEROLOGY, V81, P1006
[9] SHAND DG, 1978, LIVER QUANTITATIVE A, P346
[10] GLUCURONIDATION OF OXAZEPAM IS NOT SPARED IN PATIENTS WITH HEPATIC-ENCEPHALOPATHY
SONNE, J
ANDREASEN, PB
LOFT, S
DOSSING, M
ANDREASEN, F
[J]. HEPATOLOGY, 1990, 11 (06) : 951 - 956